We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIAM
151
Caitong International Asset Management
Hong Kong
– -$17K -1,864 Closed
AB
152
Amalgamated Bank
New York
– -$16K -1,783 Closed
GFM
153
GF Fund Management
China
– -$14.3K -1,566 Closed
PNC Financial Services Group
154
PNC Financial Services Group
Pennsylvania
– -$14K -1,531 Closed
SCM
155
Sterling Capital Management
North Carolina
– -$13.4K -1,464 Closed
PA
156
Parallel Advisors
California
– -$12.6K -1,384 Closed
TWD
157
True Wealth Design
Ohio
– -$10.9K -1,191 Closed
NECFA
158
New England Capital Financial Advisors
Connecticut
– -$10.5K -1,153 Closed
Raymond James Financial
159
Raymond James Financial
Florida
– -$9.61K -1,054 Closed
PGAM
160
Princeton Global Asset Management
New Jersey
– -$9.12K -1,000 Closed
Nisa Investment Advisors
161
Nisa Investment Advisors
Missouri
– -$8.77K -962 Closed
BIG
162
Brooklyn Investment Group
New York
– -$7.19K -788 Closed
T
163
Tidemark
California
– -$5.47K -600 Closed
MCM
164
Manchester Capital Management
Vermont
– -$5.02K -550 Closed
S
165
SignatureFD
Georgia
– -$4.88K -535 Closed
VCM
166
Versant Capital Management
Arizona
– -$4.61K -505 Closed
AF
167
Allworth Financial
California
– -$2.18K -239 Closed
Daiwa Securities Group
168
Daiwa Securities Group
Japan
– -$2K -239 Closed
RIL
169
Rothschild Investment LLC
Illinois
– -$1.87K -205 Closed
GI
170
GAMMA Investing
California
– -$1.72K -189 Closed
Comerica Bank
171
Comerica Bank
Texas
– -$1.09K -120 Closed
BIA
172
Bell Investment Advisors
California
– -$976 -107 Closed
AUB
173
Atlantic Union Bankshares
Virginia
– -$912 -100 Closed
TFM
174
TFC Financial Management
Massachusetts
– -$912 -100 Closed
Fifth Third Bancorp
175
Fifth Third Bancorp
Ohio
– -$766 -84 Closed
4 5 6
7
8

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.